(Total Views: 831)
Posted On: 09/08/2020 3:32:22 PM
Post# of 153890
UK MHRA "Path to market" could be code for price negotiations.
$4,000 course if treatment could be too expensive for mild/moderate patients???
Its also tricky for CYDY as they must set a price that will work for severe/critical as well.
$4,000 course if treatment could be too expensive for mild/moderate patients???
Its also tricky for CYDY as they must set a price that will work for severe/critical as well.
(0)
(0)
